Objectives: To evaluate the impact of 'Resident Antimicrobial Management Plan' (RAMP), a novel antimicrobial stewardship tool on systemic antibiotic use for treatment of infection in nursing homes (NHs).
Introduction
In England, there are .18 000 care homes, with .460 000 residents:
1 by nursing homes (NHs) we mean care homes with nursing. The dependency and frailty of NH residents is consistent with a high risk of infection and antimicrobial therapy. Indeed, the overall prescription rate for systemic antimicrobials for treatment and prophylaxis of infection in European NHs is reported to be 5.0%-6.5%, 2 higher than elsewhere in primary care. 3 However, many of these prescriptions may be inappropriate, 4 -8 partly because infection is more difficult to diagnose in elderly people since they often have non-specific signs of infection. In addition, it may be difficult for residents to communicate their symptoms to healthcare staff due to physical or mental impairment. It is widely recognized that inappropriate and extensive use of antimicrobials is an important factor in the emergence of antimicrobial resistance, including that seen in NHs. Such is the national concern about antimicrobial resistance that the Chief Medical Officer in England has recently called for the issue to be added to the government's national risk register, 9 which provides guidance on potential threats such as terrorist attacks, pandemic flu and major flooding. Antimicrobial treatment with broadspectrum antibiotics is acknowledged as the key risk factor for healthcare-associated infections such as Clostridium difficile infection (CDI) 10 and, more recently, urinary tract infections (UTIs) caused by extended-spectrum b-lactamase (ESBL)-producing coliforms. 11 Thus, rational and appropriate prescribing of antibiotics is likely to play an important role in the prevention of CDI and ESBL infections. Furthermore, many NH residents have frequent admissions and discharges to and from hospital, providing opportunities for the spread of healthcare-associated infections between healthcare settings. 12 Currently, there is insufficient knowledge concerning antimicrobial use, prevalence of prescribing, clinical indications or the frequency of adverse effects in NHs in the UK. With the growing need for antimicrobial stewardship in all healthcare settings, 13 it is a high priority not only to describe the current use of antimicrobials but to develop systems to optimize antimicrobial management in NHs. 14 The aim of this pilot study was to evaluate a novel antimicrobial stewardship tool, 'Resident Antimicrobial Management Plan' (RAMP), to promote good practice in antimicrobial use for treatment of infection in NHs. Although they do not prescribe, nurses have an important role in antimicrobial stewardship in NHs. Nurses are the only healthcare professionals available on site 24 h a day and are therefore primarily responsible for identifying, referring and monitoring residents with infection. RAMP documents antimicrobial prescribing, administration and monitoring. Nurses were requested to record the details but visiting doctors could refer to RAMPs at any time.
Methods

Study design
A prospective cluster randomized controlled study compliant with the CONSORT framework. 15 Ethical approval was attained prior to recruitment from the Outer West London Research Ethics Committee.
Study period
January 2010 to May 2011.
Subjects
Thirty NHs with a total of 1832 nursing beds volunteered to participate in the study. There was a mix of small independent and large corporate NH ownership. All residents were potentially eligible for inclusion. Residents received 24 h care provided by qualified nurses employed by the NHs. There were no resident doctors but medical care was provided by general practitioners (GPs) in the National Health Service. Pharmacy services were provided by contracted community pharmacies.
Consent
Consent from residents (or assent if lacking mental capacity) was obtained to collect clinical details for antimicrobial prescriptions from individual care records. GP agreement was obtained for NHs to participate in the study.
Outcome
The primary outcome measure was change in systemic antibiotic [anatomical therapeutic chemical (ATC) classes J01/P01] 16 use for treatment of infection measured as the mean number prescriptions per 100 residents (prevalence) and defined daily does (DDDs)/1000 residents/day (DRD) (total consumption).
Data collection
Data collection was during the same calendar months pre-and postintervention to account for any seasonal variation in antimicrobial use. The project manager (E. F., a specialist antimicrobial pharmacist) collected pre-intervention point prevalence data on systemic antimicrobial use from all 30 NHs on three separate occasions over 5 months (January -May 2010) and total antimicrobial consumption for a 12 week period. She also collected post-intervention data in the same manner (JanuaryMay 2011), including compliance with RAMP completion in the intervention group (IG).
Randomization
At the end of pre-intervention data collection, NHs were matched for number of nursing beds; 15 NHs were allocated randomly to the IG and 15 NHs to the control group (CG). Only the chief investigator and project manager were not blinded to the randomization.
Intervention
The intervention consisted of the introduction of the RAMP antimicrobial stewardship tool from June 2010. RAMPs were expected to be completed by nursing staff for all residents newly prescribed antimicrobial treatment. RAMP comprised a pre-printed form with two parts. 'Part A: Initiation of Treatment' was to be completed before administration of the first dose and 'Part B: Review of Treatment' commenced 48 -72 h after starting treatment. Both parts were divided into subsections or 'good practice points' (see Table 3 ) in relation to antimicrobial prescribing, administration and monitoring in line with prior Department of Health (England) recommendations 17 and the content of antimicrobial care bundles previously developed by some of the authors of this study for use in secondary care. 18, 19 The final choice of 'good practice points' for inclusion in RAMP was decided by the study steering group members.
The RAMP template comprised mainly of tick boxes for ease of completion, although 'signs or symptoms of infection' were free text by design to ascertain what nurses considered to be relevant and important to record. A support pack for nursing staff and managers was developed in lieu of regular check-up visits or training sessions. Contents included signs and symptoms of common infections in the elderly, 20 collecting clinical specimens and information on antimicrobial resistance. A dedicated telephone number for the project was provided. The RAMP tool was piloted in all 15 NHs in the IG in June 2010. Follow-up visits were made in July 2010 to ascertain whether the RAMP template required any amendment. Subsequently, some minor amendments were made to the text and tick box options. Posters and other promotional material such as bookmarks were also distributed to remind the nursing staff to refer to RAMPs and complete and file the forms in resident care records. No visits were made to NHs in the CG from June to December 2010.
Sample size
The available resources enabled a total of 30 NHs in this pilot study. At the planning stage, calculations were performed to explore the ability to detect an increased proportion of antimicrobial prescriptions adhering to RAMP. For this number of NHs, allowing for the clustered design using the estimated intraclass correlation of prescribing in primary care of 0.17 from Welschen et al. 21 and assuming that the CG would comprise 75% of prescriptions adhering to good practice guidance, 17 a 20% improvement in the IG could be detectable as being significantly different at the 5% significance level with 90% power.
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Data analysis
In the statistical analysis, total numbers of prescriptions and total DDDs in each of the NHs were obtained in both the pre-and the post-intervention phases of the study. Mixed-effects Poisson regression models with a random intercept for each NH were employed to assess the difference in both total prescriptions and total DDDs between the pre-and post-intervention phases, the total prescriptions and total DDDs being the outcome variables. The intervention and pre-post intervention were binary predictor variables, and the natural logarithm of the total number of residents or resident days were fitted as offsets to allow for differences in the size of the NHs. Comparisons were also made between the IG and the CG for the pre-and post-intervention phases regarding classes of antibiotics prescribed, type of regimen (empirical or microbiologically confirmed treatment), signs and symptoms of infection reported, clinical indications for antibiotics, source of prescriptions (where and when prescribed) and age, gender and care load of residents prescribed antibiotics. The overall percentage compliance with RAMP and percentage compliance with individual 'good practice points' within RAMP were calculated in the IG. Since it is not currently routine practice in NHs to record all these details, direct comparison cannot be made between the IG and the CG for all subsections of RAMP. Comparison was possible between the two groups regarding the clinical signs and symptoms of infection reported. We applied the 'McGeer criteria' 20 and 'revisited McGeer criteria' 22 to point prevalence data to assess the diagnosis on which the prescriptions initiated by primary care practitioners were based. Similarly, we applied the North American consensus criteria published by Loeb et al. 23 as a proxy measure for assessing the appropriateness of antibiotic prescribing.
Results
NHs ranged in size from 20 to 120 nursing beds. The number of residents potentially eligible for inclusion was 1628 for 2010 (825 IG/803 CG) and 1610 for 2011 (838 IG/772 CG). The demographics of residents' prescribed antibiotic treatment compared with all residents are shown in Table 1 . Higher percentages of males and ,65 year olds were prescribed treatment in the IG in comparison with the CG. In all 30 NHs, there was a strong association between antibiotic treatment and the presence of indwelling medical devices, wounds/pressure sores (Waterlow score grade 2+) requiring dressing or stay in another healthcare setting (hospital, hospice or other nursing/care home) within the last 90 days. A higher percentage of residents in the IG had indwelling medical devices (urinary/suprapubic catheter, percutaneous endoscopic gastrostomy, tracheostomy or vascular catheter). Rates of wounds and transfers from other healthcare settings varied slightly between the two groups.
Prescribing practices
From point prevalence data, the majority of systemic antibiotics for treatment of infection (86%) were prescribed by primary care practitioners: 82% by regular GPs and only 3% by a deputizing service and 1% by other healthcare practitioners.
The main indications were treatment of lower respiratory tract infection (LRTI), UTI and skin/soft tissue infection (SSTI). In the IG, the pattern of infection varied: pre-intervention, LRTI was the main indication (38.1%) followed by UTI (26.3%) and then SSTI (25.7%), whereas post-intervention, SSTI was the main indication (31.7%) followed by UTI (31.1%) and then LRTI (24.4%). In the CG, the order was the same in both phases: LRTI, 30.7% and 44.4%; UTI, 28.3% and 28.1%; and SSTI, 21.3% and 20.0%, respectively. From information available in NHs, very few prescriptions were based on microbiology laboratory results: in the IG, only 5.6% pre-intervention and 11.6% post-intervention; and in the CG, 8.7% and 4.4%, respectively.
Most prescriptions were issued on scheduled GP visits to NHs, although substantial proportions were issued without the prescriber visiting the resident. Telephone/facsimile prescriptions (IG, 12.5% pre-intervention and 13.4% post-intervention; and CG, 14.1% and 20.5%, respectively) were mainly for empirical treatment of UTI in the CG and in the IG pre-intervention and for positive MRSA screening results in the IG post-intervention. Repeat prescriptions for courses .28 days (IG, 5.6% preintervention and 8.5% post-intervention; and CG, 3.0% and 2.4%, respectively) were mainly for deep-seated/chronic SSTI or bone and joint infection and had been initiated in secondary care. 35 ), respectively, in the CG. The DDDs were 48% higher in the IG at baseline; this reduced but was still 34% higher in the intervention care homes during the intervention period. We therefore have presented changes from baseline in each group to provide a measure of the impact of the intervention rather than attempting to describe the direct comparison. There was a significant reduction of 4.9% (3.25 DRD) in the IG (95% CI: 1.0% -8.6%) (P ¼ 0.02) in comparison with a significant increase of 5.1% (2.24 DRD) in the CG (95% CI: 0.2%-10.2%) (P¼0.04).
In all 30 NHs, penicillins (b-lactam antibacterials, J01C) were the most widely prescribed class of antibiotics, amoxicillin being the commonest, followed by amoxicillin/clavulanic acid (co-amoxiclav) and then flucloxacillin (see Table 2 ). The standard duration of treatment prescribed was 7 days. For the classes of antibiotics with variable doses (penicillins, macrolides and cephalosporins), a greater proportion of higher doses (≥500 mg) were prescribed for residents in the IG than in the CG. Pre-intervention, the IG had 71% (295/417) high-dose prescriptions compared with 58% (187/323) in the CG (P,0.001, x 2 test of association). Post-intervention, the IG had 74% (309/416) highdose prescriptions compared with 54% (188/350) in the CG (P,0.001, x 2 test of association). There was no strong evidence Fleet et al.
that the proportions differed in the pre-and post-intervention phases of the study (P ¼ 0.11, test of interaction in a logistic regression analysis).
Compliance with RAMP
In the IG, post-intervention data collection also included compliance with completion of RAMPs. The total number available for analysis for 'Part A: Initiation of Treatment' (n ¼ 372) was higher than for 'Part B: Review of Treatment' (n¼337), as some residents were admitted to hospital or died during the course of treatment and some treatments were still continuing. Overall, 46% of RAMPs were 100% complete for Part A with a further 40% being ≥80% complete. For Part B, 31% of RAMPs were 100% complete with a further 26% being ≥80% complete. A summary of compliance with individual 'good practice points' in RAMP is shown in Table 3 . It should be noted that the figures relate to the frequency of completion only; it was not feasible to validate the information recorded.
Appropriateness of prescribing
From the signs and symptoms reported, the majority of residents partly met published definitions of infection for surveillance in long-term care facilities, the 'McGeer criteria'. 20 Although few residents fully met these criteria (in the IG 9.4% pre-and 11.1% post-intervention and in the CG 7.8% and 2.6%, respectively) a Fisher's exact test demonstrates an increased proportion of residents that fully met the 'McGeer criteria', between the IG and the CG post-intervention; the estimated relative increase is 6.44 (P ¼ 0.004). There is no evidence in the pre-intervention phase (P ¼ 0.8) as may be expected. Since our data collection 'revisited McGeer criteria' 22 have been published. Applying the new criteria lowered the percentage of residents that fully met the definitions of infection in the IG just post-intervention (to 10.4%) and in the CG to 5.8% pre-intervention and 0.9% post-intervention, respectively (see Table 4 ).
Applying the 'Loeb minimum criteria' for the initiation of antibiotics in residents of long-term care facilities 23 to assess the appropriateness of prescribing, we observed that according to the signs and symptoms reported, most prescriptions partly met the criteria. The use of RAMP was associated with an increased percentage of prescriptions that fully met the criteria in the IG (from 11.5% pre-intervention to 19.3% post-intervention) in comparison with a decreased percentage in the CG (from 12.6% to 5.1%, respectively). Statistically, the RAMP-to-baseline comparison suggested an increase in antibiotic prescriptions meeting the 'Loeb minimum criteria' (P ¼ 0.06, Fisher's exact test). However, direct comparison of the IG and the CG gave a P value of 0.001. In addition, for prescriptions that did not meet any of the Table 5 ).
In both groups and in both phases, more prescriptions for treatment of SSTI (43/139 ¼ 31%) fully met the criteria than for UTI (16/143¼11%) or LRTI (0/183¼0%).
Prevention of infection
The focus of RAMP was on treatment of infection, but we were also able to capture data on antimicrobials prescribed for prophylaxis of infection. The mean point prevalence of antibiotic prescribing for prophylaxis in the IG was 2.46% pre-intervention and 2.18% post-intervention, compared with 4.44% and 5.10%, respectively, in the CG. Total systemic antibiotic consumption (over a 12 week period) for prophylaxis of infection in the IG was 8.91 DRD preintervention and 6.19 DRD post-intervention compared with 12.34 and 13.17 DRD, respectively, in the CG. In all 30 NHs, the majority of these prescriptions were issued on a repeat basis from the regular GP practice (90.8% -95.1%) and were for prophylaxis of UTI (81.5% -92.7%). Sulphonamides and trimethoprim (J01E) represented the largest class of antibiotics prescribed.
Adverse effects
There were no untoward consequences of RAMPs.
Discussion
We have evaluated the impact of a novel antimicrobial stewardship tool, RAMP, on systemic antibiotic use for treatment of infection in NHs and also provided, for the first time, comprehensive data on the extent of use of systemic antibiotics in NHs in London. The setting for the study was 30 NHs in north-west and south-east London covering a large urban area and a diverse population of residents. The recruitment rate was 75%: 30/40 NHs invited volunteered to participate with agreement from their residents' GP practices. All 30 NHs completed the study. The change in resident numbers was due to a change in bed status from residential to nursing in one NH in the IG and refurbishment programmes reducing bed capacity in two NHs in the CG. In this study, to quantify antibiotic use we used both point prevalence studies (PPS) of prescribing of antimicrobials and measured total antimicrobial consumption over 12 weeks. The mean point prevalence of prescribing of systemic antibiotics for treatment of infection in all 30 study NHs (5.27% and 6.52%) was higher than the corresponding prevalence (4.23% and 3.66%) extracted from two large European PPS, 24, 25 though comparable to figures for Northern Ireland (7.32% and 5.18%) and the Republic of Ireland (6.68% and 6.88%) from the same European PPS, possibly reflecting similar healthcare and prescribing practices in these countries. The prevalence of antimicrobial prescribing in NHs is low but can vary considerably even on a weekly basis. PPS only measure a snapshot in time, e.g. infection outbreaks could be missed. 26 The prevalence of antibiotic prescribing for LRTI varied between the IG and the CG pre-and post-intervention, most likely due to PPS picking up or missing infection outbreaks. Ongoing data collection of total antibiotic consumption to monitor antimicrobial use in NHs is preferable to PPS as the latter may be subject to variation. Only few prescriptions (4.4% -11.6%) were based on microbiology results. These figures were considerably lower than those extracted from European PPS (23.4% and 22.5%). 24, 25 The reason for this difference is not clear. It is conceivable that no tests were ordered or results may have been returned to GPs but not forwarded to NHs. Greater guidance on the signs and symptoms of infection, such as McGeer and Loeb criteria, needs to be made available in a useful format for nursing staff and GPs. Furthermore, 20% of prescriptions were issued without the prescriber visiting the resident, i.e. following telephone/facsimile consultation or repeat prescriptions for courses .28 days. Similar observations have been made in other studies 7, 27 and although this figure compares favourably, it is clearly important to improve direct resident consultation.
Both the prevalence of antibiotic prescribing and total antibiotic consumption were greater for the IG than the CG pre-and post-intervention. Possible explanations were explored. Although NHs were matched for number of nursing beds before randomization, proportions of specialist types of beds differed in the resulting groups: IG, 61% general, 32% dementia, 5% young physically disabled (YPD), 1% palliative and 1% high dependency; and CG, 68% general, 17% dementia, 12% YPD and 3% palliative. It is possible that 'nursing care load' was greater in the IG. There is no standard scoring system and some resident characteristics/'care load indicators' are subjective. During the study, it was apparent that assessment of incontinence, disorientation and impaired mobility can vary depending on the nurse asked and that levels can fluctuate over periods of time. A strong association was seen between systemic antibiotic use and the presence of an indwelling medical device, wound requiring dressing or recent stay in another healthcare environment. A higher percentage of residents in the IG had indwelling medical devices. However, with such a pilot study with relatively small numbers of NHs, it is likely that some imbalance will remain in the actual GP prescribing habits in the NHs in the two arms. Even though the intervention was randomized, residents in NHs that eventually received the intervention happened to be prescribed more antibiotics for treatment of infection. It was considered more important to assess the change from baseline in the two groups as this indicated the relative reduction in prescribing. While adjustment for covariates is possible in regression models, the relatively small number of observations precludes too many variables being included in the model. An interesting finding was that for the most commonly prescribed classes of antibiotics with variable doses (penicillins, cephalosporins and macrolides), a greater proportion of higher doses (≥500 mg) were prescribed for residents in the IG. This obviously had a bearing on total antibiotic consumption (DDDs). There was no obvious explanation found for this difference in prescribing practice and it warrants further study. Another finding was that in contrast with antibiotic use for treatment of infection, both the prevalence and total antibiotic consumption for prophylaxis of infection was higher in the CG than in the IG, both pre-and post-intervention. Again, this warrants further study.
The RAMP intervention was to document antimicrobial prescribing, administration and monitoring. When external healthcare professionals, including regular GPs, visit a resident there is a section in the individual care record for them to document their observations, diagnosis and treatment recommendations. Although nurses, being the only healthcare professionals present 24 h a day were requested to record the details in RAMP, visiting doctors could refer to RAMPs at any time. Introduction of RAMPs Fleet et al.
was associated with a statistically significant decrease (P¼ 0.04) in total antibiotic consumption in the IG of 3.25 DRD postintervention, which would equate to 1186 days of antibiotic treatment per 1000 residents in 1 year. Comparable DRD data for European NHs are not available nor is there published evidence of what would constitute a clinically significant reduction in DRD. This aside, a positive result was achieved without any formal training programme or teaching sessions for NH staff. It is conceivable that with more training and greater involvement of main prescribers, i.e. GPs, the impact of the RAMP tool could improve over time. Overall, there was a variable uptake of the RAMP tool in the NHs. RAMP was used more frequently on initiation of empirical treatment: Part A (86%, with ≥80% complete), Part B: 48 h review of treatment was less frequently used (57%, with ≥80% complete). It is widely recognized that such a review is necessary to confirm whether there is clinical improvement and the initial empirical treatment is working. 17, 28 A cluster randomized control design was employed to evaluate the use of RAMP in antibiotic prescribing. This was because most individual NHs were served by an individual GP from one GP practice and variation in the prescribing pattern for antibiotics was more likely to be seen between NHs rather than between individual residents. Large variation in the prescribing rates of antibiotics was seen between NHs in this study, as reported in many previous studies. 2, 27, 29 Looking at antibiotic use in individual NHs in more detail, the greatest fluctuations seen pre-and post-intervention were related to the incidence of LRTI. A higher percentage of antibiotics were prescribed for treatment of UTI in one NH in the IG and two NHs in the CG, with highest usage both pre-and postintervention. No commonality in prescribing practices or demographics of residents was found for NHs with lowest antibiotic usage. This was a pilot study rather than a pivotal trial. As with many interventions, the effect will vary between centres and it is likely impossible to understand precisely why this is. However, on average, the IG had a decrease in DDDs while the CG had, on average, an increase in DDDs. For future studies, a stepped wedge design may be considered. Such a design involves sequential rollout of the intervention over a number of time periods. By the end of the study, all NHs would have received the intervention, thus allowing comparison of the impact of RAMP within each NH.
Review of the data collected in RAMPs provided other important qualitative insights into current clinical practice in NHs, including the accuracy of diagnosis and appropriateness of antimicrobial prescribing. In describing the accuracy of diagnosis, we are not aware of any UK published guidelines for the diagnosis of infection in NHs. Therefore, we used the widely adopted 4, 5, 30 North American consensus definitions of infections in long-term care facilities, the 'McGeer criteria'. 20 Most residents only partly met the criteria. However, the proportion of residents that fully met the definitions for infection ('McGeer criteria') was significantly higher in the IG compared with the CG in the intervention phase. It is important to note that the 'McGeer criteria', though they cover a wider range of infections than the 'Loeb minimum criteria', were originally developed as surveillance definitions for infection, not as diagnostic criteria. The 'revisited McGeer criteria' include the requirement for a culture-positive urine specimen for the definition of UTI and few specimens were sent in our cohort of residents. In practice, it is not easy to obtain a urine sample from an incontinent resident with dementia. Thus, there is a need to develop and disseminate universally agreed criteria for diagnosis and surveillance of NH-associated infections in the UK that do not require laboratory diagnosis.
In the absence of UK guidelines for antimicrobial treatment of infections in NHs, we used the North American consensus criteria developed by Loeb et al. 23 The proportion of prescriptions that fully met 'Loeb minimum criteria' for initiation of antibiotics was significantly higher in the IG compared with the CG in the intervention phase. Although most prescriptions partly met the criteria, around one-third did not appear to meet any of the 'Loeb minimum criteria'. We acknowledge the possibility that information regarding the signs and symptoms present may not have been accurately recorded. The 'Loeb minimum criteria' rely heavily on temperature measurements or moreover on temperature changes in relation to a resident's baseline temperature, information that we did not always find recorded. In both groups, more prescriptions for treatment of SSTI (31%) fully met the criteria than for UTI (11%) or LRTI (0%). Similarly, a recently published study by Olsho et al. 31 found only 12.7% of prescriptions could be classified as Loeb minimum criteria adherent, although there was substantial variation by infection type (1.9% adherence for LRTI, 10.2% for UTI and 42.7% for SSTI). Consistent with other studies, our findings show that inappropriate or potentially inappropriate antibiotic use in NHs is common 4 -8 and recommend that antimicrobial stewardship needs to be incorporated into infection prevention and control guidelines for NHs. 32 We also observed that GPs tended to use evidence-based management of infection guidance for the general community. 33 The latter in some cases might not be applicable for NHs given the advanced age of residents and high antibiotic resistance observed in this setting. 34 We believe specific guidance is required and tools to facilitate antimicrobial stewardship in NHs need to be developed for the UK similar to 'Start Smart-Then Focus' 28 developed for secondary care and 'TARGET antibiotics' 34 for primary care. The stewardship toolkit for NHs should include clinical practice guidelines for the evaluation of infection in NH residents, 35, 36 evidence-based prescribing guidelines, formal quality indicators and audit tools. 37 We believe that RAMP has the potential to be a part of the proposed antimicrobial stewardship toolkit in NHs.
The study had some limitations. We could not accurately assess the appropriateness of prescribing using information collected in RAMP as information was frequently incomplete or lacking sufficient clinical detail, this being the basis of the initial statistical power calculations. The overall prevalence of systemic antibiotic prescribing observed was similar to expected. However, a substantial proportion of prescriptions were for prophylaxis and there were fewer prescriptions for treatment of infection than anticipated. In the comparison of prescriptions in the point prevalence surveys in the IG and the CG, the observed reduction was not statistically significant. We acknowledge that the NHs with agreement of their GPs volunteered to participate, which could be biased towards higher standards of infection prevention and control and good prescribing practices in these NHs. We could also not control for the effects of local community antibiotic-prescribing initiatives such as discouragement of prescription of broad-spectrum antibiotics (ciprofloxacin, cephalosporins and amoxicillin/clavulanic acid) for prevention of CDI 38 and this may have had an effect on antibiotic use. Furthermore, there was insufficient information received by NHs concerning antimicrobial treatment initiated in hospital, following accident and emergency attendance or inpatient stay. This identified Pilot of antimicrobial stewardship tool in nursing homes antibiotic stewardship issue needs to be fed back to secondary care. Greater detail of diagnosis of infection in written communication at transition of care is recommended.
Conclusions
This study was the first comprehensive pilot study of antibiotic use in NHs in London. We have confirmed that infection and antibiotic prescribing are commonplace in NHs and a matter of concern for public health. The introduction of the RAMP tool for nurses was associated with a statistically significant decrease in systemic antibiotic consumption for treatment of infection. The proportions of residents prescribed antibiotics that fully met definitions for infection ('McGeer criteria') and prescriptions that fully met 'Loeb minimum criteria' for initiation of antibiotics were significantly higher in the IG compared with the CG in the intervention phase. RAMP has the potential to be an important component of any antimicrobial stewardship toolkit developed in NHs. Further studies are necessary to evaluate the impact of enhanced compliance with use of RAMPs on antibiotic usage after addressing some of the limitations recognized in this pilot study.
